{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:44:20Z","timestamp":1792532660171,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.thromres.2025.109544","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:42:42Z","timestamp":1763646162000},"page":"109544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort study"],"prefix":"10.1016","volume":"257","author":[{"given":"David","family":"Galarza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Radin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Morotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Camerlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Barinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Sciascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.thromres.2025.109544_bb0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrrheum.2017.124","article-title":"Diagnosing antiphospholipid syndrome: \u201cextra-criteria\u201d manifestations and technical advances","volume":"13","author":"Sciascia","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109544_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"82","key":"10.1016\/j.thromres.2025.109544_bb0015","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"2023","author":"Barbhaiya","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.thromres.2025.109544_bb0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1191\/0961203305lu2145rr","article-title":"Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis","volume":"14","author":"Atsumi","year":"2005","journal-title":"Lupus"},{"issue":"102327","key":"10.1016\/j.thromres.2025.109544_bb0025","article-title":"Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrual","volume":"8","author":"Gaspar","year":"2024","journal-title":"Res Pract Thromb Haemost [Internet]"},{"issue":"4","key":"10.1016\/j.thromres.2025.109544_bb0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1365-2141.1997.3063123.x","article-title":"Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome","volume":"98","author":"Godeau","year":"1997","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109544_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.70154","article-title":"Anti-phosphatidylserine\/prothrombin antibodies identify a distinct form of ITP","volume":"6","author":"Camerlo","year":"2025","journal-title":"EJHaem"},{"issue":"9","key":"10.1016\/j.thromres.2025.109544_bb0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.thromres.2025.109544_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jth.13947","article-title":"Thrombocytopenia in high-risk patients with antiphospholipid syndrome","volume":"16","author":"Pontara","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109544_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejim.2020.01.017","article-title":"Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?","volume":"74","author":"Yelnik","year":"2020","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2025.109544_bb0055","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/kez596","article-title":"Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients","volume":"60","author":"Sciascia","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.thromres.2025.109544_bb0060","series-title":"On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH - PubMed [Internet]","first-page":"1185","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update","author":"Brandt","year":"1995"},{"issue":"10","key":"10.1016\/j.thromres.2025.109544_bb0065","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation Committee of the International Society on thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109544_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030741","article-title":"Platelets and thrombotic antiphospholipid syndrome","volume":"13","author":"Tohidi-Esfahani","year":"2024","journal-title":"J. Clin. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:29:13Z","timestamp":1768012153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"alternative-id":["S0049384825002944"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109544","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombocytopenia in antiphospholipid syndrome: predictors, prognostic implications, and thrombotic risk in a large cohort study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109544"}}